Danaher Corporation, a major global pioneer in the life sciences and diagnostics, has acquired Genedata AG (“Genedata”), a prominent provider of software solutions for biopharmaceutical R&D.
Genedata, which was established in 1997 and has its headquarters in Basel, Switzerland, is a leader in the conversion of data into intelligence for the life sciences sector.
Genedata serves leading international biopharmaceutical businesses and cutting-edge biotechnology organizations worldwide, providing scalable and open technologies that improve R&D productivity.
It is anticipated that Genedata’s products will complement Danaher’s extensive workflow solutions, which aid in accelerating the pace of drug discovery, development, and manufacturing for vital new treatments.
Read also- Hong Kong-Based DocPro has Secured $500k in Pre Seed Round Funding
In the last few years, Genedata and Danaher have collaborated successfully on multiple occasions.
“Genedata is a global market leader in digitalizing R&D processes to help accelerate the delivery of lifesaving and personalized medicines. Our achievements are driven by the dedication and expertise of our teams, whose efforts have been instrumental in earning the trust of our customers,” said Othmar Pfannes, Ph.D., Founder and CEO of Genedata. “As a Danaher operating company, Genedata will seek to continue to attract the brightest talent and solve our customers’ hardest problems globally.”
Danaher is a pioneer in the diagnostics and life sciences. Its companies collaborate closely with clients to address numerous major health issues that affect patients globally.
Read also- Singapore-Based Singtel Strategic Partnership with Bridge Alliance
Its cutting-edge research and technology contribute to quicker, more precise diagnoses as well as shorter, more sustainable development, testing, and delivery times for treatments that can save lives.
“Throughout our trusted relationship with Genedata, we have long admired their innovative software systems anchored in deep scientific expertise. We share a commitment to supporting biopharma companies to accelerate the development of much-needed therapies by providing innovative solutions that help researchers access high-quality insights,” said Greg Milosevich, Vice President and Group Executive of Danaher’s DH Life Sciences LLC subsidiary. “We are excited to welcome their team to Danaher and intend to continue expanding Genedata’s capabilities to address new technologies and requirements in this quickly evolving field.”
About Genedata
Genedata‘s revolutionary software solutions use biopharma R&D domain knowledge to turn data into intelligence. Global biopharmaceutical companies and cutting-edge biotechs use Genedata to digitalize and automate data-rich and complex R&D processes.
About Danaher Corporation
Danaher is a global life sciences and diagnostics firm dedicated to accelerating research and technology to enhance health. Companies collaborate with customers to address many of the world’s biggest health issues.
